Posts

Is this how antidepressants work, and why they take wee...

Type of work: peer-reviewed/randomised controlled trial/people Credit: (credit: ...

Biologics emerge as dominating molecule type in solid t...

Traditionally, the pharmaceutical landscape has been dominated by small molecul...

EASD 2023: Effectiveness of GLP-1 Agonists vs. DPP-4Is ...

At the 59th Annual European Association for the Study of Diabetes (EASD) 2023 m...

Ocular launches ocular implant trial to combat macular ...

US biopharmaceutical firm, Ocular Therapeutix has announced the start of its fi...

Emergex and VIC to develop infectious disease therapies...

Emergex Vaccines has signed a Memorandum of Understanding (MoU) with the Vaccin...

FDA panel says Amgen’s Phase III lung cancer KRAS drug ...

A US Food and Drug Administration (FDA’s) Oncology Advisory Committee (AdCom) h...

Thermo Fisher expands US manufacturing plant to support...

Thermo Fisher Scientific has expanded its manufacturing capacity at its St....

Signal: Serum Institute of India plans to increase glob...

Serum Institute of India, a vaccine manufacturer, has historically focused on s...

TREAT California embarks on plan to earn $5bn for psych...

A nonprofit in California has started a major signature campaign for a November...

Twist Bioscience and Bayer partner for antibody discovery

Genomics company Twist Bioscience has entered an antibody discovery, option and...

AbbVie to bolster neuroscience pipeline with Mitokinin ...

AbbVie has acquired discovery-stage biotechnology company Mitokinin in a $655m ...

STAT+: Inflammation gets its own research center, thank...

A New Chan Zuckerberg Biohub in Chicago will focus on inflammation, starting wit...

STAT+: Judge dismisses Novo Nordisk lawsuit over compou...

In a setback for Novo Nordisk, a U.S. judge dismissed its lawsuit accusing a com...

STAT+: Long underappreciated, gamma-delta T cells may b...

New research suggests an understudied immune cell, the gamma-delta T cell, has s...

NIH funds expanded access projects for ALS

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: FDA panel lacks confidence in Amge...

A FDA advisory panel voted 10-2 that the data for Amgen's Lumakras lung cancer t...